Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay)
Research Disclaimer: This product is synthesized strictly for laboratory research and development purposes
Join our list for twice-monthly updates from your Waukee-area aesthetics, skincare, and wellness experts
Beginning semaglutide treatment is an encouraging step toward better health, whether youre managing type 2 diabetes or aiming for weight loss
The most common side effect is nausea , particularly when you first start the medication or increase the dose
DOI: 10.1056/NEJMoa2032183 [^2]: Rubino D, Abrahamsson N, Davies M, et al